Medicaid Reform Could Change Your Work Life - Webinar
By Benjamin Chambers, October 12 2010
Just like the Transformer shown morphing above from a car into a robot, health reform will bring enormous changes for adolescent substance abuse treatment providers and behavioral healthcare agencies in general.
That's why it's important not to miss this one-hour webinar, "Medicaid Reform," on October 14, 2010 at noon PST / 3 pm EST. (Hat tip to Faces and Voices of Recovery.)
Sponsored by ACMHA (The College for Behavioral Healthcare Leadership), the webinar speaker will be Barbara Coulter Edwards, Centers for Medicare and Medicaid Services. Register here.
Questions? Email Kris Ericson, Executive Director of ACMHA.
Can't attend? Don't worry - all webinars will be archived with the rest of ACMHA's monthly webinar series on health reform legislation.

Once upon a time, in the 1990s, Ecstasy was a rave drug, surrounded by whirling glow-sticks and teenagers looking for a good time. When organizations like the Foundation for a Drug-Free World started spreading the word about Ecstasy’s hazards via public service announcements, the drug began to go out of style. As with most drugs, education is prevention. Today, the general population is well aware that users of Ecstasy, also known as MDMA, are at a high risk for dangerous side effects such as mental trauma, memory loss, seizure, stroke, and kidney failure. Dr. Caitlin Reed of the U.S. Centers for Disease Control and Prevention puts it simply: “There are multiple mechanisms through which Ecstasy can cause death.”
Juvenile Justice System News and Speculation
Researchers have learned a great deal about what works in addiction treatment in the last ten years. But many organizations still have trouble translating research into practice -- so-called "technology transfer." 